Andrew Messina, DPM
Podiatrist · Columbus, INNPI 1972161016
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Pinnacle, Inc at 32.8% of the total. Reporting peaked in 2022 at $3,218 and has fallen 77.8% since, to $714 in 2025.
Across 100 payments — averaging $86.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$3K
- Medline Industries LP$2K
- Stryker$737
- Arthrex$486
- Johnson & Johnson$388
- Integra Lifesciences Corporation$342
- plus $2K from 29 others
What the payments were for
- Travel & lodging$2,00123%
- Food & beverage$3,58641%
- Education$3,04835%
- Gifts$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 7 | $2,836 |
| Medline Industries LP | 7 | $1,813 |
| Stryker | 5 | $737 |
| Arthrex | 13 | $486 |
| Johnson & Johnson(2 entities) | 8 | $388 |
| Integra Lifesciences Corporation | 3 | $342 |
| Smith+Nephew | 10 | $294 |
| AbbVie | 5 | $199 |
| Kerecis Limited | 7 | $184 |
| Organogenesis Inc. | 3 | $178 |
| Biocomposites Inc | 1 | $143 |
| Sanara Medtech Inc. | 1 | $135 |
| Biopoly LLC | 1 | $129 |
| Amgen | 1 | $110 |
| Paragon 28, Inc. | 2 | $97 |
| Solventum Corporation | 3 | $95 |
| Zimmer Biomet | 1 | $69 |
| Tactile Systems Technology Inc | 2 | $42 |
| Averitas Pharma Inc. | 2 | $41 |
| Dynasplint Systems Inc. | 1 | $36 |
| Medtronic | 2 | $35 |
| Convatec Inc. | 1 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $28 |
| Abbott | 1 | $24 |
| Bioventus LLC | 1 | $23 |
| Surgenex LLC | 1 | $21 |
| MF MED | 1 | $18 |
| Inari Medical, Inc. | 1 | $18 |
| Reprise Biomedical, Inc. | 1 | $18 |
| Vertex | 1 | $18 |
| Hartmann USA, Inc. | 1 | $16 |
| Next Science LLC | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Reapplix Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$921
- Actishield$648
- INTEGRA DERMAL REGENERATION TEMPLATE$307
- PRIMATRIX$307
- Stimulan$143
- CellerateRx$135
- PuraPly$123
- DALVANCE$123
- KRYSTEXXA$110
- PICO$104
- XARELTO$100
How this compares
$8,657 in reported general payments places this provider in the 85th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 21 | $172 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Columbus
- Robert MiddletonColumbus$2K
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
- John RachoyMunster$21K
- Townsen KenningtonFort Wayne$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.